Prescriber's Guide – Children and Adolescents
Cambridge University Press (Verlag)
978-1-009-26750-2 (ISBN)
This extensively revised second edition provides a user-friendly step-by-step manual on the range of psychotropic medications prescribed for children and adolescents by clinicians and nurse practitioners. Boasting nearly double the medications of the first edition, it features new sections related to pharmacokinetics and pharmacogenetics in children and adolescents alongside algorithms for addressing frequently encountered disorders such as anxiety, depression, bipolar disorder, ADHD, and OCD. Based on the best-seller, Stahl's Prescriber's Guide, and using a full-color template-driven navigation system, it combines evidence-based data with clinically informed guidance to support prescribers in the field. Each drug is presented in the same classic design format with illustrated guidance on dosing, titration, and pharmacogenetics/metabolism. Color-coded sections distinguish clearly the information presented on therapeutics, safety and tolerability, dosing and use, what to expect, and the art of psychopharmacology, and are followed by updated and new key references. A must-have guide for all mental health professionals.
Stephen M. Stahl, M.D. is Adjunct Professor of Psychiatry at the University of California, San Diego, Clinical Professor of Psychiatry and Neuroscience at the University of California, Riverside, and Honorary Visiting Senior Fellow in Psychiatry at the University of Cambridge. He is also Clinical Professor of Psychiatry in Norton College of Medicine at Upstate Medical University. Jeffrey R. Strawn, M.D. is Professor of Psychiatry & Behavioral Neuroscience in the College of Medicine, University of Cincinnati, Cincinnati, Ohio. He holds secondary appointments in the Department of Pediatrics in the Divisions of Clinical Pharmacology and Child & Adolescent Psychiatry.
Introduction; List of icons; 1. Alprazolam; 2. Amphetamine (d); 3. Amphetamine (d,l); 4. Amitriptyline; 5. Aripiprazole; 6. Asenapine; 7. Atomoxetine; 8. Brexpiprazole; 9. Bupropion; 10. Buspirone; 11. Carbamazepine; 12. Chlorpromazine; 13. Citalopram; 14. Clomipramine; 15. Clonazepam; 16. Clonidine; 17. Clozapine; 18. Cyproheptadine; 19. Desmopressin; 20. Desvenlafaxine; 21. Diazepam; 22. Diphenhydramine; 23. Doxylamine; 24. Duloxetine; 25. Escitalopram; 26. Esketamine; 27. Fluoxetine; 28. Fluphenazine; 29. Fluvoxamine; 30. Gabapentin; 31. Guanfacine; 32. Haloperidol; 33. Hydroxyzine; 34. Lamotrigine; 35. Lisdexamfetamine; 36. Lithium; 37. Lorazepam; 38. Lurasidone; 39. methylphenidate (d); 40. methylphenidate (d,l); 41. Mirtazapine; 42. Olanzapine; 43. Oxcarbazepine; 44. Paliperidone; 45. Paroxetine; 46. Pimozide; 47. Prazosin; 48. Quetiapine; 49. Risperidone; 50. Serdexmethylphenidate; 51. Sertraline; 52. Topiramate; 53. Trazodone; 54. Valproate; 55. Venlafaxine; 56. Vilazodone; 57. Viloxazine; 58. Vortioxetine; 59. Zolpidem; Appendix; Index by drug name; Index by drug use; Index by drug class; Abbreviations.
Erscheinungsdatum | 02.05.2024 |
---|---|
Mitarbeit |
Stellvertretende Herausgeber: Jeffrey R. Strawn |
Zusatzinfo | Worked examples or Exercises |
Verlagsort | Cambridge |
Sprache | englisch |
Maße | 138 x 228 mm |
Gewicht | 870 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
ISBN-10 | 1-009-26750-7 / 1009267507 |
ISBN-13 | 978-1-009-26750-2 / 9781009267502 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich